Viewing StudyNCT04523662



Ignite Creation Date: 2024-05-06 @ 3:06 PM
Last Modification Date: 2024-10-26 @ 1:43 PM
Study NCT ID: NCT04523662
Status: UNKNOWN
Last Update Posted: 2020-08-21
First Post: 2020-08-06

Brief Title: Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer
Sponsor:
Organization: Beijing Tsinghua Chang Gung Hospital